A Call for Transparency, Improved Reporting and Interpretation of Trials Using Surrogate Endpoints in Cardiac Electrophysiology

By sjmartinez • March 2, 2025

Tereshchenko LG, Manyara AM, Ciani O, Sodeke SO, Bradford CN, Santangeli P, Kapadia SR, Wazni O, Narayan SM, Chugh SS, Bilchick K, Huizar JF, Vaseghi M, Chung MK, Ellenbogen KA, Taylor RS. A Call for Transparency, Improved Reporting and Interpretation of Trials Using Surrogate Endpoints in Cardiac Electrophysiology. Heart Rhythm. 2025 Feb 26:S1547-5271(25)00209-7. doi: 10.1016/j.hrthm.2025.02.038. Epub ahead of print. PMID: 40021073.

Tags: Biomarker, Cardiology/Epi, Checklist, Clinical Trial, Outcome, Publications, Randomized Controlled Trial, Research design, standards, surrogate endpoint, surrogate marker

Mouse models of aortic aneurysm and dissection: pathophysiological insights and translational perspectives

He C, Yanagisawa H, Hsiai TK, Xu S. Mouse models of aortic aneurysm and dissection: pathophysiological insights and translational perspectives. J Adv Res. 2026 Aug[...]

Target Versus Below-Target Dose ACE Inhibitors in U.S. Veterans with HFpEF: Differential Outcomes by CKD Status

Lu F, Ahmed AA, Zhang S, Raman VK, Patel SS, Vargas JD, Fonarow GC, Heidenreich PA, Cleland JGF, Anker SD, Böhm M, Metra M, Zile[...]

Heart Failure with Preserved Ejection Fraction in Women: Sex-Specific Insights Across the Continuum from Diagnosis to Outcomes

Andrade-Bucknor S, Barforoshi S, Le DE, Lyubarova R, Chung J. Heart Failure with Preserved Ejection Fraction in Women: Sex-Specific Insights Across the Continuum from Diagnosis[...]